Case Studies
A case study is a research strategy and an empirical inquiry that investigates a phenomenon within its real-life context. Case studies are based on an in-depth investigation of a single individual, group or event to explore the causes of underlying principles.
- Breast neoplasms
- Carcinoma
- Duct ectasia
Related Conference of Case Studies
August 22-23, 2022
2nd International Conference on Biomarkers and Clinical Research
Barcelona, Spain
September 12-12, 2022
36th International Conference on Cancer Science & Therapy
Amsterdam, Netherlands
September 23-24, 2022
17th World Congress on Biomarkers, Cancer Therapy & Clinical Research
Vancouver, Canada
September 24-25, 2022
3rd International Conference on Oncodiagnostics and Cancer Research
Vancouver, Canada
Case Studies Conference Speakers
Recommended Sessions
- Breast Cancer and Cell Biology
- Breast Cancer and Immunology
- Breast Cancer Awareness
- Breast Cancer Detection, Prevention and Diagnosis
- Breast Cancer Management
- Breast Cancer Nursing
- Breast Cancer Risk
- Breast Cancer Staging
- Breast Cancer Surgery
- Breast Cancer-Clinical Trials
- Case Studies
- Diet and lifestyle effect on Breast Cancer
- Epidemiology of breast cancer and Risk Factors
- Inflammatory Breast Cancer
- Male Breast Cancer Research
- Mammography
- Radiology
Related Journals
Are you interested in
- Cancer Metastasis - Cell Signaling 2022 (Canada)
- Advances in Cancer Detection - Euro Oncology 2022 (France)
- Advances in epigenetic technology - Epigenetics 2022 (Austria)
- Alternative and Complementary Medicine - BRECECAN 2022 (Spain)
- Alternative and Complimentary Therapies - ONCOLOGY MEET 2022 (UK)
- Antibody-based Therapeutics Against Cancer - Frontiers In Cancer 2022 (Japan)
- Anticancer drug - Preventive Oncology 2022 (Germany)
- Antineoplastic drugs - RADIOCANCER - 2022 (France)
- Bioinformatics and biostatics in epigenetic disease markers and targets - Epigenetics 2022 (Austria)
- Biomarkers - Biomarkers 2022 (Canada)
- Biomarkers Case Reports - Biomarkers 2022 (Canada)
- Biomarkers for Disorders - Biomarkers 2022 (Canada)
- Biomarkers in Clinical Research and Development - Biomarkers 2022 (Canada)
- Biomarkers in Drug Discovery - Biomarkers 2022 (Canada)
- Biomarkers in Market - Biomarkers 2022 (Canada)
- Biomarkers in Microbial Infections - Biomarkers 2022 (Canada)
- Biomarkers in Nanoscience - Biomarkers 2022 (Canada)
- Biomarkers in Toxicology - Biomarkers 2022 (Canada)
- Biomarkers of Exposure Response and Susceptibility - Biomarkers 2022 (Canada)
- Biomarkers: Entrepreneur Investments Meet - Biomarkers 2022 (Canada)
- Bladder Cancer - Euro Oncology 2022 (France)
- Brain Cancer - Euro Oncology 2022 (France)
- Brain Tumor - Epigenetics 2022 (Austria)
- Brain tumor - Preventive Oncology 2022 (Germany)
- Breast Cancer - BREAST CANCER MEET 2022 (UK)
- Breast Cancer - WOMEN ONCOLOGY 2022 (Thailand)
- Breast Cancer - Breast Cancer-2022 (Canada)
- Breast cancer - CANCER THERAPY MEETING 2022 (Australia)
- Breast Cancer and Cell Biology - BREAST CANCER MEET 2022 (UK)
- Breast Cancer and Genetics - Breast Cancer-2022 (Canada)
- Breast Cancer and Immunology - BREAST CANCER MEET 2022 (UK)
- Breast cancer and the Immune system - Breast Cancer-2022 (Canada)
- Breast Cancer Biology - BRECECAN 2022 (Spain)
- Breast Cancer Clinical Trials - Breast Cancer-2022 (Canada)
- Breast Cancer Detection, Prevention and Diagnosis - BREAST CANCER MEET 2022 (UK)
- Breast cancer detection, Prevention and diagnosis - Euro Oncology 2022 (France)
- Breast Cancer during pregnancy - BREAST CANCER MEET 2022 (UK)
- Breast Cancer Nursing - BRECECAN 2022 (Spain)
- Breast Cancer Nursing - Breast Cancer-2022 (Canada)
- Breast Cancer Nursing - BREAST CANCER MEET 2022 (UK)
- Breast Cancer Radiation Therapy - BREAST CANCER MEET 2022 (UK)
- Breast Cancer Recurrence - Breast Cancer-2022 (Canada)
- Breast Cancer Research - Frontiers In Cancer 2022 (Japan)
- Breast Cancer Risk - BREAST CANCER MEET 2022 (UK)
- Breast Cancer Risk Factors - Breast Cancer-2022 (Canada)
- Breast Cancer Surgery - BREAST CANCER MEET 2022 (UK)
- Breast Cancer Therapies - BREAST CANCER MEET 2022 (UK)
- Breast Cancer treatment - BREAST CANCER MEET 2022 (UK)
- Breast Cancer, Cancer Therapies And Breast Cancer Treatment - World Oncology 2022 (UAE)
- Breast Cancer, Cancer Therapies And Breast Cancer Treatment - Women Oncology 2022 (Canada)
- Breast Cancer: Clinical trials - BREAST CANCER MEET 2022 (UK)
- Breast Implants - Breast Cancer-2022 (Canada)
- Breast Microcalcifications - Breast Cancer-2022 (Canada)
- Breastfeeding and Breast Cancer - BRECECAN 2022 (Spain)
- Cancer & Therapeutics - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Cancer and Stem Cell Therapy - World Cancer 2022 (Switzerland)
- Cancer Awareness and Survival - WOMEN ONCOLOGY 2022 (Thailand)
- Cancer Awareness and Survival - World Cancer 2022 (Switzerland)
- Cancer Bioinformatics - Preventive Oncology 2022 (Germany)
- Cancer Bioinformatics - ONCOLOGY MEET 2022 (UK)
- Cancer Biology - World Oncology 2022 (UAE)
- Cancer Biology - Women Oncology 2022 (Canada)
- Cancer Biology - RADIOCANCER - 2022 (France)
- Cancer Biology - CANCER THERAPY MEETING 2022 (Australia)
- Cancer Biomarkers - CANCER THERAPY MEETING 2022 (Australia)
- Cancer Biomarkers - WOMEN ONCOLOGY 2022 (Thailand)
- Cancer Biomarkers - World Oncology 2022 (UAE)
- Cancer Biomarkers - Women Oncology 2022 (Canada)
- Cancer Biomarkers - Preventive Oncology 2022 (Germany)
- Cancer Biomarkers - Cell Signaling 2022 (Canada)
- Cancer Biomarkers - Frontiers In Cancer 2022 (Japan)
- Cancer Biomarkers - World Cancer 2022 (Switzerland)
- Cancer Biomarkers - Biomarkers 2022 (Canada)
- Cancer Biopsy - World Cancer 2022 (Switzerland)
- Cancer Cell Biology - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Cancer Cell Biology and Cancer Biomarker - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Cancer Cell Biology and Genetics - World Cancer 2022 (Switzerland)
- Cancer Cell Signaling - WOMEN ONCOLOGY 2022 (Thailand)
- Cancer Cell Signalling & Pathways - Frontiers In Cancer 2022 (Japan)
- Cancer Chemotherapy - World Cancer 2022 (Switzerland)
- Cancer Chemotherapy - CANCER THERAPY MEETING 2022 (Australia)
- Cancer Control & Population Health - WOMEN ONCOLOGY 2022 (Thailand)
- Cancer detection and diagnosis - ONCOLOGY MEET 2022 (UK)
- Cancer Development - Women Oncology 2022 (Canada)
- Cancer Development - World Oncology 2022 (UAE)
- Cancer Diagnostics: From Research to Clinical Practice - Frontiers In Cancer 2022 (Japan)
- Cancer Drugs - World Oncology 2022 (UAE)
- Cancer Drugs - Euro Oncology 2022 (France)
- Cancer Drugs - Women Oncology 2022 (Canada)
- Cancer drugs and vaccines - ONCOLOGY MEET 2022 (UK)
- Cancer Epidemiology - Frontiers In Cancer 2022 (Japan)
- Cancer Epidemiology - CANCER THERAPY MEETING 2022 (Australia)
- Cancer Epidemiology - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Cancer Epidemiology - ONCOLOGY MEET 2022 (UK)
- Cancer Epidemiology, Screening, Diagnosis & Prognosis - Women Oncology 2022 (Canada)
- Cancer Epidemiology, Screening, Diagnosis & Prognosis - World Oncology 2022 (UAE)
- Cancer Genetics - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Cancer Genetics - Cell Signaling 2022 (Canada)
- Cancer Genetics - CANCER THERAPY MEETING 2022 (Australia)
- Cancer Genetics & Epigenetics - Frontiers In Cancer 2022 (Japan)
- Cancer Genetics and Epigenetics - Cancer and Care 2022 (USA)
- Cancer Health Disparities - World Oncology 2022 (UAE)
- Cancer Health Disparities - Women Oncology 2022 (Canada)
- Cancer Immunology - ONCOLOGY MEET 2022 (UK)
- Cancer Immunology & Immunotherapy - Cancer and Care 2022 (USA)
- Cancer Immunology & Immunotherapy - Frontiers In Cancer 2022 (Japan)
- Cancer Immunology & Immunotherapy - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Cancer Immunotherapy & Vaccines - RADIOCANCER - 2022 (France)
- Cancer lifestyle and nutrition - ONCOLOGY MEET 2022 (UK)
- Cancer Metabolism - Frontiers In Cancer 2022 (Japan)
- Cancer Metabolomics - World Cancer 2022 (Switzerland)
- Cancer Metastasis - Cancer and Care 2022 (USA)
- Cancer Metastasis - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Cancer Metastasis - World Cancer 2022 (Switzerland)
- Cancer Mode of Existence - Preventive Oncology 2022 (Germany)
- Cancer Nanotechnology - World Cancer 2022 (Switzerland)
- Cancer Nanotechnology - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Cancer nanotechnology - ONCOLOGY MEET 2022 (UK)
- Cancer Nanotechnology - Preventive Oncology 2022 (Germany)
- Cancer Pathophysiology - ONCOLOGY MEET 2022 (UK)
- Cancer Pathophysiology - Preventive Oncology 2022 (Germany)
- Cancer Pharmacology - World Cancer 2022 (Switzerland)
- Cancer Pharmacology - CANCER THERAPY MEETING 2022 (Australia)
- Cancer Pharmacology - ONCOLOGY MEET 2022 (UK)
- Cancer Pharmacology - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Cancer Pharmacology - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Cancer Pharmacology & Cytopathology - Cell Signaling 2022 (Canada)
- Cancer Prevention - Frontiers In Cancer 2022 (Japan)
- Cancer Prevention & Research - CANCER THERAPY MEETING 2022 (Australia)
- Cancer prevention and Care - Cancer and Care 2022 (USA)
- Cancer Prevention and Research - World Cancer 2022 (Switzerland)
- Cancer Prevention and Research - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Cancer Preventive Vaccines: Oncolytic Therapy & Others - World Oncology 2022 (UAE)
- Cancer Preventive Vaccines: Oncolytic Therapy & Others - Women Oncology 2022 (Canada)
- Cancer Rehabilitation - RADIOCANCER - 2022 (France)
- Cancer Risk Factors - World Oncology 2022 (UAE)
- Cancer Risk Factors - Women Oncology 2022 (Canada)
- Cancer Science - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Cancer Science - World Oncology 2022 (UAE)
- Cancer Science - Women Oncology 2022 (Canada)
- Cancer Screening - WOMEN ONCOLOGY 2022 (Thailand)
- Cancer screening - Cancer and Care 2022 (USA)
- Cancer Screening and detection - ONCOLOGY MEET 2022 (UK)
- Cancer Stem Cells - Frontiers In Cancer 2022 (Japan)
- Cancer Stem Cells - Women Oncology 2022 (Canada)
- Cancer Stem cells - Cell Signaling 2022 (Canada)
- Cancer Stem Cells - World Oncology 2022 (UAE)
- Cancer Therapeutics - Cell Signaling 2022 (Canada)
- Cancer Therapeutics and Novel Approaches - Preventive Oncology 2022 (Germany)
- Cancer Therapy - Preventive Oncology 2022 (Germany)
- Cancer Therapy - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Cancer Therapy & Treatments - CANCER THERAPY MEETING 2022 (Australia)
- Cancer Therapy & Treatments - Frontiers In Cancer 2022 (Japan)
- Cancer Therapy, Prevention and Medicine - BRECECAN 2022 (Spain)
- Cancer Treatment - World Oncology 2022 (UAE)
- Cancer Treatment - Women Oncology 2022 (Canada)
- Cancer treatment and therapies - ONCOLOGY MEET 2022 (UK)
- Cancer Vaccines - Women Oncology 2022 (Canada)
- Cancer Vaccines - Frontiers In Cancer 2022 (Japan)
- Cancer Vaccines - World Cancer 2022 (Switzerland)
- Cancer Vaccines - Cell Signaling 2022 (Canada)
- Cancer Vaccines - World Oncology 2022 (UAE)
- Cancer Vaccines - Cancer and Care 2022 (USA)
- Cancer: Lifestyle Connection and Nutrition - World Cancer 2022 (Switzerland)
- Cancer: Psychological and Social Aspects - World Cancer 2022 (Switzerland)
- Cancer: Psychological Aspects - WOMEN ONCOLOGY 2022 (Thailand)
- Cancers of specific organs - RADIOCANCER - 2022 (France)
- Carcinogenesis. - Frontiers In Cancer 2022 (Japan)
- Carcinogens in cosmetics - RADIOCANCER - 2022 (France)
- Cardio Oncology - Women Oncology 2022 (Canada)
- Cardio Oncology - World Oncology 2022 (UAE)
- Cell & Gene Therapy - Cell Signaling 2022 (Canada)
- Cell Biology - Cell Signaling 2022 (Canada)
- Cell biology of cancer - Preventive Oncology 2022 (Germany)
- Cell Metabolism - Cell Signaling 2022 (Canada)
- Cell Signaling - Cell Signaling 2022 (Canada)
- Cervical Cancer - WOMEN ONCOLOGY 2022 (Thailand)
- Cervical Cancer Biology - BRECECAN 2022 (Spain)
- Chemotherapy - WOMEN ONCOLOGY 2022 (Thailand)
- Chromatin analysis - Epigenetics 2022 (Austria)
- Chromatin domains and structure - Epigenetics 2022 (Austria)
- Circulating Tumor Cell (CTC) - World Oncology 2022 (UAE)
- Circulating Tumor Cell (CTC) - Women Oncology 2022 (Canada)
- Circulating Tumor Cells - Frontiers In Cancer 2022 (Japan)
- Clinical Neonatology - NEONATAL ONCOLOGY 2022 (Japan)
- Clinical Pediatrics - NEONATAL ONCOLOGY 2022 (Japan)
- Colorectal Cancer - Euro Oncology 2022 (France)
- Colorectal Cancer Progression - Frontiers In Cancer 2022 (Japan)
- Complementary & Alternative Methods and Cancer - CANCER THERAPY MEETING 2022 (Australia)
- Complementary and Alternative Methods and Cancer - World Cancer 2022 (Switzerland)
- Computational Analysis of Cancer - Frontiers In Cancer 2022 (Japan)
- Computational modeling - Epigenetics 2022 (Austria)
- COVID-19 and its impact on Cancer patients - Frontiers In Cancer 2022 (Japan)
- Current Research Concepts in Biomarkers - Biomarkers 2022 (Canada)
- Diet and lifestyle effect on Breast Cancer - BREAST CANCER MEET 2022 (UK)
- DNA & RNA sequencing - Epigenetics 2022 (Austria)
- Drug Resistance - Frontiers In Cancer 2022 (Japan)
- Endometrial Cancer - WOMEN ONCOLOGY 2022 (Thailand)
- Environmental Epigenetic Factor - Epigenetics 2022 (Austria)
- Epidemiology of breast cancer and Risk Factors - BREAST CANCER MEET 2022 (UK)
- Epigenetics - Epigenetics 2022 (Austria)
- Epigenetics and epigenomics - Epigenetics 2022 (Austria)
- Epigenetics and stem cell reprogramming - Epigenetics 2022 (Austria)
- Epigenetics in bacteria - Epigenetics 2022 (Austria)
- Epigenetics in cancer - Preventive Oncology 2022 (Germany)
- Epigenetics in psychology and psychiatry - Epigenetics 2022 (Austria)
- Epigenetics Reproductive Health - Epigenetics 2022 (Austria)
- Epigenome and transcriptome editing - Epigenetics 2022 (Austria)
- Fragment analysis - Epigenetics 2022 (Austria)
- Functional Genomics and Cytogenetic Biomarkers - Biomarkers 2022 (Canada)
- Functional Transcriptomics and Profiling Techniques - Biomarkers 2022 (Canada)
- Functions and consequences: development and transgenerational - Epigenetics 2022 (Austria)
- Gastrointestinal cancer - Preventive Oncology 2022 (Germany)
- General tests for Brest Cancer - BRECECAN 2022 (Spain)
- Genetic Mutations Of Cancer - World Oncology 2022 (UAE)
- Genetic Mutations Of Cancer - Women Oncology 2022 (Canada)
- Genomes editing - Epigenetics 2022 (Austria)
- Genomic Medicine - ONCOLOGY MEET 2022 (UK)
- Gerson therapy - Preventive Oncology 2022 (Germany)
- Gynaecologic Oncology - Euro Oncology 2022 (France)
- Gynaecological cancers - RADIOCANCER - 2022 (France)
- Gynecologic Oncology - Women Oncology 2022 (Canada)
- Gynecologic Oncology - World Oncology 2022 (UAE)
- Haematology - ONCOLOGY MEET 2022 (UK)
- Hematological Cancers - RADIOCANCER - 2022 (France)
- Hematological Tumors - Frontiers In Cancer 2022 (Japan)
- Hormone replacement therapy - ONCOLOGY MEET 2022 (UK)
- Immune Responses & DNA Repair – Cancer Fields - Frontiers In Cancer 2022 (Japan)
- Immunology and Breast Cancer - BRECECAN 2022 (Spain)
- Immunotherapy - CANCER THERAPY MEETING 2022 (Australia)
- Inflammatory Breast Cancer - BREAST CANCER MEET 2022 (UK)
- Innovations of Cancer Research and Oncology - ONCOLOGY MEET 2022 (UK)
- Innovative Cancer Science: Translating Biology to Medicine - Frontiers In Cancer 2022 (Japan)
- Integrative care - WOMEN ONCOLOGY 2022 (Thailand)
- Interventional Radiology - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Key role of Pathology in cancer - Euro Oncology 2022 (France)
- Lifestyle and Nutrition for Cancer - Cancer and Care 2022 (USA)
- Liver Cancer - CANCER THERAPY MEETING 2022 (Australia)
- Lung Cancer - Frontiers In Cancer 2022 (Japan)
- Lung Cancer - Preventive Oncology 2022 (Germany)
- Lung Cancer - WOMEN ONCOLOGY 2022 (Thailand)
- Magnetic Resonance Imaging (MRI) - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Male Breast Cancer Research - BREAST CANCER MEET 2022 (UK)
- Mammography - BREAST CANCER MEET 2022 (UK)
- Mastectomy - BREAST CANCER MEET 2022 (UK)
- Measurement and mapping of genomic - Epigenetics 2022 (Austria)
- Medical Imaging Technology - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Metastatic Breast Cancer - BREAST CANCER MEET 2022 (UK)
- Metastatic Cancer - Preventive Oncology 2022 (Germany)
- Mylenoma - RADIOCANCER - 2022 (France)
- Nanopore Sequencing of Cancer Genomics - Frontiers In Cancer 2022 (Japan)
- Nanotechnology / Nanomedicines in Cancer Treatment - BRECECAN 2022 (Spain)
- Nanotechnology In Cancer Treatment - World Oncology 2022 (UAE)
- Nanotechnology In Cancer Treatment - Women Oncology 2022 (Canada)
- Neonatal & Pediatric Endocrinology - NEONATAL ONCOLOGY 2022 (Japan)
- Neonatal & Pediatric Hematology - NEONATAL ONCOLOGY 2022 (Japan)
- Neonatal & Pediatric Imaging - NEONATAL ONCOLOGY 2022 (Japan)
- Neonatal & Pediatric Immunology - NEONATAL ONCOLOGY 2022 (Japan)
- Neonatal & Pediatric leukemia - NEONATAL ONCOLOGY 2022 (Japan)
- Neonatal & Pediatric Nutrition - NEONATAL ONCOLOGY 2022 (Japan)
- Neonatal & Pediatric Oncology - NEONATAL ONCOLOGY 2022 (Japan)
- Neonatal & Pediatric Oncology Diagnosis - NEONATAL ONCOLOGY 2022 (Japan)
- Neonatal & Pediatric Pulmonology - NEONATAL ONCOLOGY 2022 (Japan)
- Neonatal & Pediatric Radiology - NEONATAL ONCOLOGY 2022 (Japan)
- Neonatal and Pediatric Oncology - World Cancer 2022 (Switzerland)
- Neonatal And Pediatric Oncology - World Oncology 2022 (UAE)
- Neonatal And Pediatric Oncology - Women Oncology 2022 (Canada)
- Neonatology & Pediatrics - NEONATAL ONCOLOGY 2022 (Japan)
- Neuro-oncology - Preventive Oncology 2022 (Germany)
- Neuro-oncology: focuses on cancers of brain - Epigenetics 2022 (Austria)
- Neuroblastoma - NEONATAL ONCOLOGY 2022 (Japan)
- Neuroradiology and Neuro Oncology - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Next Generation Cancer Models - Frontiers In Cancer 2022 (Japan)
- Novel Approaches to Cancer Therapeutics - BRECECAN 2022 (Spain)
- Nucleosome positioning - Epigenetics 2022 (Austria)
- Nutritional Biomarkers - Biomarkers 2022 (Canada)
- Omics Technologies in Biomarkers Discovery and Validation - Biomarkers 2022 (Canada)
- Oncologists: Biomarkers - Biomarkers 2022 (Canada)
- Oncology - WOMEN ONCOLOGY 2022 (Thailand)
- Oncology - Epigenetics 2022 (Austria)
- Oncology Nursing - World Oncology 2022 (UAE)
- Oncology Nursing - Women Oncology 2022 (Canada)
- Oncology nursing - Preventive Oncology 2022 (Germany)
- Oncology Nursing - WOMEN ONCOLOGY 2022 (Thailand)
- Oncology Nursing and Care - World Cancer 2022 (Switzerland)
- Oncology Nursing and Care - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Oncology Research - World Oncology 2022 (UAE)
- Oncology Research - Women Oncology 2022 (Canada)
- Oncology research categories - ONCOLOGY MEET 2022 (UK)
- Oncology: Sub-Specialities - CANCER THERAPY MEETING 2022 (Australia)
- Oncology: Sub-Specialties - World Cancer 2022 (Switzerland)
- Ophthalmic Oncology - Euro Oncology 2022 (France)
- Organ Specific Cancer - Women Oncology 2022 (Canada)
- Organ Specific Cancer - Cancer and Care 2022 (USA)
- Organ Specific Cancer - World Oncology 2022 (UAE)
- Organ-Defined Cancers - World Cancer 2022 (Switzerland)
- Organ-Defined Cancers - CANCER THERAPY MEETING 2022 (Australia)
- Organ-Defined Cancers - Frontiers In Cancer 2022 (Japan)
- Other Cancers - BREAST CANCER MEET 2022 (UK)
- Ovarian Cancer - WOMEN ONCOLOGY 2022 (Thailand)
- Palliative Care - ONCOLOGY MEET 2022 (UK)
- Palliative care for Cancer - NEONATAL ONCOLOGY 2022 (Japan)
- Pediatric Dermatology - NEONATAL ONCOLOGY 2022 (Japan)
- Pediatric Neuro Oncology - NEONATAL ONCOLOGY 2022 (Japan)
- Pediatric Oncology - Euro Oncology 2022 (France)
- Pediatric Oncology Nursing - NEONATAL ONCOLOGY 2022 (Japan)
- Personalized Medicine and Data Analysis - Biomarkers 2022 (Canada)
- Phases And Types Of Clinical Trails - World Oncology 2022 (UAE)
- Phases And Types Of Clinical Trails - Women Oncology 2022 (Canada)
- Plants Against Cancer - Preventive Oncology 2022 (Germany)
- Precision Cancer Medicine & Oncology - CANCER THERAPY MEETING 2022 (Australia)
- Precision Medicine And Immuno-Oncology - World Oncology 2022 (UAE)
- Precision Medicine And Immuno-Oncology - Women Oncology 2022 (Canada)
- Protein interaction analysis - Epigenetics 2022 (Austria)
- Protein Signaling & Neuronal Signaling - Cell Signaling 2022 (Canada)
- Pulmonary Oncology - World Oncology 2022 (UAE)
- Pulmonary Oncology - Women Oncology 2022 (Canada)
- Radiation & Chemotherapy - Cell Signaling 2022 (Canada)
- Radiation oncology - Preventive Oncology 2022 (Germany)
- Radiation Oncology - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Radiation Oncology - World Oncology 2022 (UAE)
- Radiation Oncology - Frontiers In Cancer 2022 (Japan)
- Radiation Oncology - Women Oncology 2022 (Canada)
- Radiation Oncology - Euro Oncology 2022 (France)
- Radiation Oncology Nursing - Euro Oncology 2022 (France)
- Radiation Therapy - WOMEN ONCOLOGY 2022 (Thailand)
- Radiation Therapy for Cancer - RADIOCANCER - 2022 (France)
- Radiology - BREAST CANCER MEET 2022 (UK)
- Radiology Trends and Technology - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Radiology Trends and Technology - Euro Oncology 2022 (France)
- Radiology/Cancer Imaging - Frontiers In Cancer 2022 (Japan)
- Radiopharmaceuticals - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Radiotherapy - CANCER THERAPY MEETING 2022 (Australia)
- Radiotherapy and Chemotherapy - RADIOLOGY AND ONCOLOGY 2022 (Spain)
- Reconstruction of breast cancer - Breast Cancer-2022 (Canada)
- Retinoblastoma - RADIOCANCER - 2022 (France)
- RNA transcripts, MicroRNAs, mRNA, and sRNA - Epigenetics 2022 (Austria)
- Robotic surgery for cancer treatment - Preventive Oncology 2022 (Germany)
- Screening tests - Preventive Oncology 2022 (Germany)
- Screening, Detecting and Diagnosing - BRECECAN 2022 (Spain)
- Signal Transduction - Cell Signaling 2022 (Canada)
- Signaling Pathways & Diseases - Cell Signaling 2022 (Canada)
- Single-cell and Spatial Multiomics in Cancer Research - Frontiers In Cancer 2022 (Japan)
- Skin Cancer - Preventive Oncology 2022 (Germany)
- Skin cancers - Frontiers In Cancer 2022 (Japan)
- Solid Tumors - Frontiers In Cancer 2022 (Japan)
- Stages of Cancer - ONCOLOGY MEET 2022 (UK)
- Stem Cell Therapy - CANCER SCIENCE CONGRESS 2022 (Netherlands)
- Structural inheritance - Epigenetics 2022 (Austria)
- Surgeries involved in Breast Cancer - Breast Cancer-2022 (Canada)
- Surgery Choices for Breast Cancer - BRECECAN 2022 (Spain)
- Surgical Oncology - Frontiers In Cancer 2022 (Japan)
- Surgical oncology - Preventive Oncology 2022 (Germany)
- Techniques to Maximize Biomarker Identification - Biomarkers 2022 (Canada)
- The Application of Clinical Proteomics for Precision Oncology - Frontiers In Cancer 2022 (Japan)
- Therapies in Neonatal & Pediatric Oncology - NEONATAL ONCOLOGY 2022 (Japan)
- Treating Breast Cancer with Chemotherapy - Breast Cancer-2022 (Canada)
- Tumor Heterogeneity and Cancer Metastasis - Frontiers In Cancer 2022 (Japan)
- Tumor virology - Preventive Oncology 2022 (Germany)
- Tumor Virology, Immunology and Cellular Pathology - World Cancer 2022 (Switzerland)
- Tumors heterogeneity - Preventive Oncology 2022 (Germany)
- Tumour Microenvironment - Frontiers In Cancer 2022 (Japan)
- Tumour screening and clinical management - RADIOCANCER - 2022 (France)
- Types of Cancer - ONCOLOGY MEET 2022 (UK)
- Types Of Cancers - World Oncology 2022 (UAE)
- Types Of Cancers - Women Oncology 2022 (Canada)
- Veterinary Oncology - World Oncology 2022 (UAE)
- Veterinary Oncology - Women Oncology 2022 (Canada)
- Women’s Health and Contraception - BRECECAN 2022 (Spain)